Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar

Side effects of Anti-Tuberculosis Drugs (ATD) is a problem in the treatment of TB patients. The severity of the side effects experienced by patients will have an impact on treatment compliance and loss to follow-up rate. This study aimed to obtain information about ATD side effects experienced by pu...

Full description

Bibliographic Details
Main Author: Akhmadi Abbas
Format: Article
Language:English
Published: University of Jember, Faculty of Medicine 2017-02-01
Series:Journal of Agromedicine and Medical Sciences (AMS)
Online Access:https://jurnal.unej.ac.id/index.php/JAMS/article/view/4093
_version_ 1811173127487488000
author Akhmadi Abbas
author_facet Akhmadi Abbas
author_sort Akhmadi Abbas
collection DOAJ
description Side effects of Anti-Tuberculosis Drugs (ATD) is a problem in the treatment of TB patients. The severity of the side effects experienced by patients will have an impact on treatment compliance and loss to follow-up rate. This study aimed to obtain information about ATD side effects experienced by pulmonary TB patients during the intensive phase treatment in Makassar. This type of research was observational descriptive with the time series design. The number of samples in this study were 58 people. The results showed that the percentage of patients who experienced ATD side effects during the intensive phase of treatment is the first week of 96.6%, 91.4% the second week, third week of 86.2%, 74.1% fourth week, the fifth week 74.1% , the sixth week 81%, the seventh week of 75.9% and 67.2% eighth week. The percentage of patients based on the type of side effects experienced is 81% joint pain, nausea 79.3%, 77.6% itching, loss of appetite 75.9%, 67.2% dizziness, tingling 50%, vomiting 41.4%, 34.5% abdominal pain, visual disturbances 27.6%, headache 24.1% and 6.9% hearing loss. This study showed that patients experienced ATD side effects every week during the intensive phase treatment. More side effects experienced during the first and the second weeks and tend to decrease until the end of the intensive phase. The main type of side effects experienced by TB patients are joint pain. Health workers should always conduct routine monitoring of ATD side effects experienced by TB patients in order to improve patient treatment compliance and prevent them from loss to follow-up of treatment. Keywords: Monitoring, Side effects, ATD, TB, Intensive phase
first_indexed 2024-04-10T17:42:40Z
format Article
id doaj.art-ea62d43c93ee46b1be8657af36de4971
institution Directory Open Access Journal
issn 2460-9048
2714-5654
language English
last_indexed 2024-04-10T17:42:40Z
publishDate 2017-02-01
publisher University of Jember, Faculty of Medicine
record_format Article
series Journal of Agromedicine and Medical Sciences (AMS)
spelling doaj.art-ea62d43c93ee46b1be8657af36de49712023-02-03T12:18:15ZengUniversity of Jember, Faculty of MedicineJournal of Agromedicine and Medical Sciences (AMS)2460-90482714-56542017-02-0131192410.19184/ams.v3i1.40934093Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In MakassarAkhmadi AbbasSide effects of Anti-Tuberculosis Drugs (ATD) is a problem in the treatment of TB patients. The severity of the side effects experienced by patients will have an impact on treatment compliance and loss to follow-up rate. This study aimed to obtain information about ATD side effects experienced by pulmonary TB patients during the intensive phase treatment in Makassar. This type of research was observational descriptive with the time series design. The number of samples in this study were 58 people. The results showed that the percentage of patients who experienced ATD side effects during the intensive phase of treatment is the first week of 96.6%, 91.4% the second week, third week of 86.2%, 74.1% fourth week, the fifth week 74.1% , the sixth week 81%, the seventh week of 75.9% and 67.2% eighth week. The percentage of patients based on the type of side effects experienced is 81% joint pain, nausea 79.3%, 77.6% itching, loss of appetite 75.9%, 67.2% dizziness, tingling 50%, vomiting 41.4%, 34.5% abdominal pain, visual disturbances 27.6%, headache 24.1% and 6.9% hearing loss. This study showed that patients experienced ATD side effects every week during the intensive phase treatment. More side effects experienced during the first and the second weeks and tend to decrease until the end of the intensive phase. The main type of side effects experienced by TB patients are joint pain. Health workers should always conduct routine monitoring of ATD side effects experienced by TB patients in order to improve patient treatment compliance and prevent them from loss to follow-up of treatment. Keywords: Monitoring, Side effects, ATD, TB, Intensive phasehttps://jurnal.unej.ac.id/index.php/JAMS/article/view/4093
spellingShingle Akhmadi Abbas
Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
Journal of Agromedicine and Medical Sciences (AMS)
title Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
title_full Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
title_fullStr Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
title_full_unstemmed Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
title_short Monitoring Of Side Effects Of Anti-Tuberculosis Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary TB Patients In Makassar
title_sort monitoring of side effects of anti tuberculosis drugs atd on the intensive phase treatment of pulmonary tb patients in makassar
url https://jurnal.unej.ac.id/index.php/JAMS/article/view/4093
work_keys_str_mv AT akhmadiabbas monitoringofsideeffectsofantituberculosisdrugsatdontheintensivephasetreatmentofpulmonarytbpatientsinmakassar